Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

ERK

Items 11-17 of 17

Page
per page
  1. XMD17-109
    A3942 XMD17-109
    Target: ERK
    Summary: ERK-5 inhibitor
      ≥31.95 mg/mL
  2. VX-11e
    A3931 VX-11e
     5 Citation
    Target: ERK
    Summary: ERK inhibitor
      ≥25 mg/mL
  3. 2',5'-Dihydroxyacetophenone
    C7132 2',5'-Dihydroxyacetophenone
    Summary: A naturally derived acetophenone that inhibits ERK1/2 and NF-κB signaling for inflammatory disease
      ≥27.4 mg/mL
  4. ONC201
    A8724 ONC201
    Summary: A DRD2 antagonist and ClpP activator that also inhibits the AKT and ERK pathways.
  5. Pareruptorin A
    N2885 Pareruptorin A
    Summary: An angular pyranocoumarin compound derived from Peucedanum praeruptorum Dunn.
      ≥50.8 mg/mL
  6. UK122 HCl
    BA8332A UK122 HCl
    Summary: UK122 is a potent and highly selective and cell-permeable uPA (Urokinase-type plasminogen activator) inhibitor
  7. UK122 TFA
    BA8332B UK122 TFA
    Summary: UK122 is a potent and highly selective and cell-permeable uPA (Urokinase-type plasminogen activator) inhibitor

Items 11-17 of 17

Page
per page